Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
1 hedge funds and large institutions have $11K invested in Bio Green Med Solution Inc Preferred Stock in 2019 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
0.03% more ownership
Funds ownership: 0.68% → 0.71% (+0.03%)
0% more funds holding
Funds holding: 1 → 1 (0)
8% less capital invested
Capital invested by funds: $12K → $11K (-$1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$543 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $11K | +$543 | +100 | +4% |
|
BGMSP Hedge Fund Activity: Q1 2019 in Review
1 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q1 2019, worth a combined $11K — down 8.3% from $12K a quarter earlier.
Fund positioning in BGMSP was balanced in Q1 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $543.
- 1 institutional investor held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $11K of Bio Green Med Solution Inc Preferred Stock stock for Q1 2019, down 8.3% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q1 2019 and 0 closed out.
- The largest Bio Green Med Solution Inc Preferred Stock buyer in Q1 2019 was UBS Group, an estimated $543 added.
Based on aggregated 13F filings for Q1 2019.